Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
PEGASUS-TIMI 54 sub-analysis shows importance of continuing treatment with BRILINTA beyond one year following a heart attack
-
AstraZeneca to present further research into long-term prevention of cardiovascular events for patients with a history of heart attack at ESC Congress 2015
-
AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
-
AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial
-
MedImmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
-
AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
-
MedImmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer
-
AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases
-
AstraZeneca PLC H1 2015 results
-
AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
Latest articles and press releases
All of our latest press releases and articles are available to explore
